Delivery Order SPE2DB20D2002-SPE2DB24FL25Q

Award Date 2/16/24
Potential Completion Date 2/20/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,453.62 firm fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,466.45, is for the delivery of Fenofibrate 145 mg tablets. It is a firm fixed-price delivery order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,407.74, is a Firm Fixed Price Delivery Order for the supply of Fenofibrate 48 mg Tablet Unit Dose (30s). The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $107,703.25, is for the delivery of Fenofibrate 145 mg tablets over the period ending on April 4, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fenofibrate 145 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,945.55 and a period of performance through January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fenofibrate 145 mg tablets. The contract, valued at $4,712.97, is a firm fixed-price delivery order contract that runs through August 18, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award is for the delivery of Fenofibrate 145 mg tablets in 90-count packages. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $22,636.70, and has a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,410.24 firm fixed price delivery order (SPE2DB22D3011|SPE2DB24FQ0PL) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564261717 Fenofibrate 145 mg Tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,365.23 and a period of performance through April 7, 2025. The contract is for the delivery of Fenofibrate 50 mg capsules to support federal healthcare programs. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,367.88 firm-fixed-price contract is for the delivery of fenofibrate 160 mg tablets to support federal healthcare programs. The contract is not designated as a set-aside and appears to be an open competition award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL25Q
    Delivery Order

This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL25Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,553.99 firm fixed-price delivery order is for the supply of 4563689488 Fenofibrate 145 mg tablets, with a completion date of February 20, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/14/25, 10:18 AM